Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772077761> ?p ?o ?g. }
- W2772077761 endingPage "421" @default.
- W2772077761 startingPage "410" @default.
- W2772077761 abstract "Abstract The emergence of immunotherapy has revolutionized cancer treatment in recent years. Inhibitors of immune checkpoints, including antibodies against cytotoxic T-lymphocyte-associated protein 4, programmed cell death protein 1, and programmed death ligand 1, have demonstrated notable efficacy in certain advanced cancers. Unfortunately, many patients do not benefit from these therapies and either exhibit primary resistance to treatment or develop acquired mechanisms of resistance after initially responding to therapy. Here, we review the genomic and immune traits that may promote resistance to T-cell-mediated immunotherapy, with a focus on identifying potential biomarkers that could eventually be used in the clinical setting to guide treatment selection. We summarize the clinical evidence for these markers and discuss how current understanding of resistance mechanisms can inform future studies and aid clinical decision-making in order to derive maximum benefit from immunotherapy. Implications for Practice Immunotherapy has rapidly progressed as a treatment modality for multiple cancers, but it is still unclear which patients are likely to benefit from these therapies. Studies of resistance mechanisms have only recently started to identify biomarkers that can help predict patient outcomes. This review summarizes the available clinical data in regard to immunotherapy resistance, with a focus on molecular biomarkers that may be useful in guiding clinical decision-making. It discusses possible applications of these biomarkers and highlights opportunities for further clinical discovery." @default.
- W2772077761 created "2017-12-22" @default.
- W2772077761 creator A5043526350 @default.
- W2772077761 creator A5061285204 @default.
- W2772077761 creator A5081588858 @default.
- W2772077761 date "2017-12-18" @default.
- W2772077761 modified "2023-09-24" @default.
- W2772077761 title "Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions" @default.
- W2772077761 cites W1498931318 @default.
- W2772077761 cites W1601679057 @default.
- W2772077761 cites W1759669640 @default.
- W2772077761 cites W1898887656 @default.
- W2772077761 cites W1940241680 @default.
- W2772077761 cites W1942897646 @default.
- W2772077761 cites W1944707476 @default.
- W2772077761 cites W1947375451 @default.
- W2772077761 cites W1981528932 @default.
- W2772077761 cites W1982488143 @default.
- W2772077761 cites W1988474688 @default.
- W2772077761 cites W2006759360 @default.
- W2772077761 cites W2008322756 @default.
- W2772077761 cites W2010121426 @default.
- W2772077761 cites W2011458181 @default.
- W2772077761 cites W2013090484 @default.
- W2772077761 cites W2014545440 @default.
- W2772077761 cites W2017251888 @default.
- W2772077761 cites W2026861011 @default.
- W2772077761 cites W2028433016 @default.
- W2772077761 cites W2033672531 @default.
- W2772077761 cites W2037342985 @default.
- W2772077761 cites W2038914273 @default.
- W2772077761 cites W2039123767 @default.
- W2772077761 cites W2042470707 @default.
- W2772077761 cites W2047265596 @default.
- W2772077761 cites W2047958526 @default.
- W2772077761 cites W2049553585 @default.
- W2772077761 cites W2050407789 @default.
- W2772077761 cites W2051083170 @default.
- W2772077761 cites W2052787920 @default.
- W2772077761 cites W2054475219 @default.
- W2772077761 cites W2057893793 @default.
- W2772077761 cites W2060070314 @default.
- W2772077761 cites W2065423665 @default.
- W2772077761 cites W2066671159 @default.
- W2772077761 cites W2079018735 @default.
- W2772077761 cites W2080886891 @default.
- W2772077761 cites W2089536793 @default.
- W2772077761 cites W2094390470 @default.
- W2772077761 cites W2094945358 @default.
- W2772077761 cites W2095808484 @default.
- W2772077761 cites W2097995306 @default.
- W2772077761 cites W2099432296 @default.
- W2772077761 cites W2104347254 @default.
- W2772077761 cites W2104885590 @default.
- W2772077761 cites W2107429737 @default.
- W2772077761 cites W2107598346 @default.
- W2772077761 cites W2109485845 @default.
- W2772077761 cites W2112121482 @default.
- W2772077761 cites W2112523832 @default.
- W2772077761 cites W2113906692 @default.
- W2772077761 cites W2114903025 @default.
- W2772077761 cites W2116376943 @default.
- W2772077761 cites W2122403898 @default.
- W2772077761 cites W2123363005 @default.
- W2772077761 cites W2123918574 @default.
- W2772077761 cites W2124427232 @default.
- W2772077761 cites W2125616358 @default.
- W2772077761 cites W2128035403 @default.
- W2772077761 cites W2128758225 @default.
- W2772077761 cites W2132566055 @default.
- W2772077761 cites W2133075384 @default.
- W2772077761 cites W2135808990 @default.
- W2772077761 cites W2138134458 @default.
- W2772077761 cites W2139591061 @default.
- W2772077761 cites W2142300779 @default.
- W2772077761 cites W2143105454 @default.
- W2772077761 cites W2143163879 @default.
- W2772077761 cites W2143772132 @default.
- W2772077761 cites W2148300747 @default.
- W2772077761 cites W2149121521 @default.
- W2772077761 cites W2152897456 @default.
- W2772077761 cites W2155189639 @default.
- W2772077761 cites W2157269800 @default.
- W2772077761 cites W2157428298 @default.
- W2772077761 cites W2160834915 @default.
- W2772077761 cites W2164772840 @default.
- W2772077761 cites W2165456770 @default.
- W2772077761 cites W2166662937 @default.
- W2772077761 cites W2169083371 @default.
- W2772077761 cites W2175480754 @default.
- W2772077761 cites W2179115666 @default.
- W2772077761 cites W2185075416 @default.
- W2772077761 cites W2198093519 @default.
- W2772077761 cites W2201214180 @default.
- W2772077761 cites W2201379305 @default.
- W2772077761 cites W2210073947 @default.
- W2772077761 cites W2222086386 @default.
- W2772077761 cites W2256481109 @default.